These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23256697)

  • 1. Integrated clinical genomics: new horizon for diagnostic and biomarker discoveries in cancer.
    Roukos DH
    Expert Rev Mol Diagn; 2013 Jan; 13(1):1-4. PubMed ID: 23256697
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovative biomarker development for personalized medicine in breast cancer care.
    Zografos GC; Roukos DH
    Biomark Med; 2011 Feb; 5(1):73-8. PubMed ID: 21319967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.
    Legolvan MP; Taliano RJ; Resnick MB
    Hum Pathol; 2012 Aug; 43(8):1157-68. PubMed ID: 22658275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of molecular biomarkers in individualized treatment of colorectal cancer.
    De Mattos-Arruda L; Dienstmann R; Tabernero J
    Clin Colorectal Cancer; 2011 Dec; 10(4):279-89. PubMed ID: 21729679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems and prospects of non-invasive screening for colorectal cancer].
    Maev IV; Govorun VM; Kucheriavyĭ IuA; Golubev NN; Generozov EV; Maslov VV; LiubeznovA IIu; Kostin PA
    Klin Med (Mosk); 2009; 87(7):10-6. PubMed ID: 19705783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Omics docking and molecular classification in colorectal cancer].
    Peng Y; Shen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1201-6. PubMed ID: 21131745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics of colorectal and breast cancer.
    Garrett CT; Liscia DS; Nasim S; Ferreira-Gonzalez A
    Clin Lab Med; 1995 Dec; 15(4):957-71. PubMed ID: 8838233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the science: molecular classifications of breast cancer for clinical diagnostics.
    Robison JE; Perreard L; Bernard PS
    Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualizing care for women with early-stage breast cancer: the role of molecular assays.
    Litsas G
    Clin J Oncol Nurs; 2013 Jun; 17(3):332-4. PubMed ID: 23715711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics, personalized medicine and cancer practice.
    Dancey J
    Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
    [No Abstract]   [Full Text] [Related]  

  • 14. Summaries for patients. Personalizing age of cancer screening cessation.
    Ann Intern Med; 2014 Jul; 161(2):. PubMed ID: 25023262
    [No Abstract]   [Full Text] [Related]  

  • 15. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors.
    Lind GE; Ahlquist T; Lothe RA
    Gastroenterology; 2007 Apr; 132(4):1631-2; author reply 1632. PubMed ID: 17408629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker update for breast, colorectal and non-small cell lung cancer.
    Ross JS
    Drug News Perspect; 2010; 23(1):82-8. PubMed ID: 20155222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genomic diagnosis in breast cancer practice].
    Masuda S
    Rinsho Byori; 2012 Oct; 60(10):969-74. PubMed ID: 23323462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.